Celularity (CELU) Tax Provisions (2019 - 2024)
Celularity (CELU) posted quarterly Tax Provisions of -$1000.0 for Q4 2024, down 110.0% year-over-year from $10000.0 in Q1 2024, and down 110.0% quarter-over-quarter from $10000.0 in Q4 2023.
Celularity (CELU) Tax Provisions (2019 - 2024) Analysis & Trends
Celularity (CELU) has reported Tax Provisions for 6 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Tax Provisions fell 110.0% year-over-year to -$1000.0; the TTM figure through Dec 2024 stood at -$1000.0 (down 110.0% YoY), while the FY2025 annual figure was $3000.0, up 400.0% from the prior year.
- Tax Provisions slipped to -$1000.0 in Q4 2024 per CELU's latest filing, from $10000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $4.6 million in Q4 2020 and bottomed at -$43700.0 in Q1 2021.
- Historically, Tax Provisions has averaged $411622.4 across 5 years, with a median of $14000.0 in 2020.
- On a YoY basis, Tax Provisions climbed as much as 2206.44% in 2020 and fell as far as 122.63% in 2020.
- Celularity's Tax Provisions stood at $4.6 million in 2020, then plunged by 99.57% to $20000.0 in 2021, then plunged by 35.0% to $13000.0 in 2022, then retreated by 23.08% to $10000.0 in 2023, then tumbled by 110.0% to -$1000.0 in 2024.
- Business Quant data shows CELU's Tax Provisions at -$1000.0 in Q4 2024, $10000.0 in Q4 2023, and $13000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | Celularity | 21.75 Mn | 15.58 Mn | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | -17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Jun 30, 2021 | 43,700.00 |
| Mar 31, 2021 | -43,700.00 |
| Dec 31, 2020 | 4.65 Mn |
| Sep 30, 2020 | 15,000.00 |
| Jun 30, 2020 | -38,170.00 |
| Mar 31, 2020 | 272,639.00 |
| Dec 31, 2019 | 201,523.00 |
| Sep 30, 2019 | 298,032.00 |
| Jun 30, 2019 | 168,675.00 |